Aptamer Group PLC (AIM:APTA)
0.3078
-0.0172 (-5.29%)
Oct 15, 2026, 1:18 PM GMT
Aptamer Group Revenue
In the fiscal year ending June 30, 2026, Aptamer Group had annual revenue of 1.54M GBP with 28.35% growth. Aptamer Group had revenue of 716.00K in the half year ending June 30, 2026, with 27.40% growth. That makes Aptamer Group the 42,311th largest company in the world by revenue and 829th in the United Kingdom.
Revenue
1.54M
Revenue Growth
+28.35%
P/S Ratio
7.27
Revenue / Employee
51.47K
Employees
30
Market Cap
10.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1.54M | 341.00K | 28.35% |
| Jun 30, 2025 | 1.20M | 343.00K | 39.88% |
| Jun 30, 2024 | 860.00K | -892.00K | -50.91% |
| Jun 30, 2023 | 1.75M | -2.28M | -56.59% |
| Jun 30, 2022 | 4.04M | 3.18M | 372.29% |
| Mar 31, 2020 | 854.57K | -132.09K | -13.39% |
| Mar 31, 2019 | 986.66K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Palatin Technologies | 9.94M |
| IXICO | 7.28M |
| SkinBioTherapeutics | 5.23M |
| Fusion Antibodies | 2.11M |
| OptiBiotix Health | 1.29M |
| Oxford BioDynamics | 1.20M |
| Genflow Biosciences | 585.61K |
| CRISM Therapeutics | 352.00K |
Aptamer Group News
- 1 day ago - Full Year 2026 Aptamer Group PLC Earnings Presentation for Investors Transcript - GuruFocus
- 3 months ago - Aptamer Group moves into Ebola diagnostics - The Armchair Trader
- 6 months ago - Half Year 2026 Aptamer Group PLC Earnings Presentation Transcript - GuruFocus
- 6 months ago - Aptamer Group: Partnership cash helping to fund development - The Armchair Trader
- 9 months ago - Aptamer Enters Licensing Agreement With Alphazyme - Nasdaq
- 1 year ago - Full Year 2025 Aptamer Group PLC Earnings Presentation Transcript - GuruFocus
- 1 year ago - AIM Market Roundup: HSS Hire, Aptamer, EQTEC - The Armchair Trader
- 1 year ago - Aptamer Group launches biomarker discovery service to expand revenue base - The Armchair Trader